Comparison
6q Terminal Deletion Syndrome C4304514 vs 2 Hydroxyadipic Aciduria C5826412
Clinical comparison between 6Q Terminal Deletion Syndrome and 2 Hydroxyadipic Aciduria for differential diagnosis and treatment planning.
6q Terminal Deletion Syndrome C4304514
A chromosomal disorder involving deletion of genetic material at the end of chromosome 6, leading to developmental delays and variable physical features.
2 Hydroxyadipic Aciduria C5826412
A metabolic condition where certain acids accumulate abnormally. It can impact energy metabolism and neurological function. Treatment typically involves dietary modifications and monitoring.
6 comparison axes
Onset
6q Terminal Deletion Syndrome C4304514
0-0
2 Hydroxyadipic Aciduria C5826412
0-null
Onset patterns differ
Severity
6q Terminal Deletion Syndrome C4304514
severe
2 Hydroxyadipic Aciduria C5826412
moderate
Different severity levels
Chronic
6q Terminal Deletion Syndrome C4304514
Chronic
2 Hydroxyadipic Aciduria C5826412
Chronic
Differing course
Communicable
6q Terminal Deletion Syndrome C4304514
No
2 Hydroxyadipic Aciduria C5826412
No
Different transmission
Body System
6q Terminal Deletion Syndrome C4304514
congenital
2 Hydroxyadipic Aciduria C5826412
metabolic
Same/different system
Category
6q Terminal Deletion Syndrome C4304514
genetic
2 Hydroxyadipic Aciduria C5826412
metabolic
Different category
Bottom line
6q-terminal-deletion-syndrome-C4304514 and 2-hydroxyadipic-aciduria-C5826412 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 6q Terminal Deletion Syndrome C4304514 | 2 Hydroxyadipic Aciduria C5826412 | Discriminating power |
|---|---|---|---|
| Development | Developmental delay is described, with onset at birth. | Neurologic function may be affected; timing is not established. | Moderate |
| Physical features | Variable congenital physical features may occur. | No characteristic congenital pattern is established in the source. | Moderate |
| Metabolism | Not described as organic-acid accumulation. | Certain acids accumulate and may affect energy metabolism. | High |
When to favor each condition
Choose 6q Terminal Deletion Syndrome C4304514 when
A terminal chromosome 6 deletion is confirmed
Direct genetic evidence supports this congenital diagnosis.
High
Congenital delay and variable physical features predominate
This pattern fits the supplied chromosomal description better.
Moderate
No metabolic acid abnormality is identified
The presentation is more consistent with a genetic structural disorder.
Low
Choose 2 Hydroxyadipic Aciduria C5826412 when
2-hydroxyadipic acid accumulation is documented
The biochemical finding supports the named metabolic condition, pending confirmation.
High
Neurologic or energy-metabolism concerns suggest a metabolic disorder
This aligns with the supplied description rather than a chromosomal deletion.
Moderate
Dietary modification and biochemical monitoring are central
These are described supports, not proof of diagnosis or dosing guidance.
Moderate
How key tests differ
| Test | 6q Terminal Deletion Syndrome C4304514 | 2 Hydroxyadipic Aciduria C5826412 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify a terminal 6q deletion. | Does not establish this metabolic condition. | A confirmed deletion supports the left concept; a normal result does not prove the right one. |
| Urine organic acid analysis | No specific acid pattern is established here. | May show abnormal 2-hydroxyadipic acid; no cutoff is supplied. | An abnormal result is a finding and requires clinician confirmation. |
| Targeted genetic or metabolic evaluation | Focuses on deletion mapping and counseling. | Assesses the metabolic abnormality and its relevance. | Selection should be individualized because evidence is limited. |
Prognosis comparison
6q Terminal Deletion Syndrome C4304514
- Outcome
- Described as severe and chronic, but individual outcome is not fully established.
- Factors
- Deletion extent, development, congenital features, and available support.
2 Hydroxyadipic Aciduria C5826412
- Outcome
- Described as moderate and chronic, with uncertain neurologic and metabolic impact.
- Factors
- Acid accumulation, neurologic involvement, diet, and monitoring.
Time frame: A lifelong course is suggested, but precise milestones are unavailable.
Etiology, severity, early recognition, and individualized care influence outlook.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental impairment | Developmental delay is a described core feature. Neurologic effects are possible but not quantified. Severity labels differ, while individual outcomes remain variable. |
| Metabolic disturbance | Not described as a core feature. Acid accumulation may affect energy metabolism. No frequency, crisis criteria, or laboratory thresholds are supplied. |
| Long-term care needs | Chronic congenital care and developmental support may be needed. Dietary modification and monitoring may be needed. Burden, mortality, and exact treatment are not established. |
Patient education highlights
- HighFinding versus diagnosis
A suspected deletion or abnormal acid result needs specialist confirmation before a definitive diagnosis.
- HighDifferent causes
One condition is chromosomal; the other involves abnormal metabolic acid accumulation.
- MediumMonitoring
Report developmental, neurologic, feeding, or energy changes promptly; avoid unsupervised dietary restriction.